Clinical Trials Browser

Interventional × Hematologic Neoplasms × Interferon alpha-2 × Clear all

NCT04379518 2026-01-13

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Phase 1/2 Terminated

4 enrolled 30 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Phase 2 Completed

LymphoidOther hematologic neoplasm

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms

NCT00001567 2008-03-04

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Hairy Cell, Hematologic Neoplasms